Haynes Boone advised ENvue Medical Holdings Corp. (ENvue) in its acquisition with NanoVibronix, Inc. to create a platform for growth and expand market reach in the medical device sector.
The acquisition, structured as a stock-for-stock transaction, resulted in ENvue holding approximately 85 percent of the consolidated entity, with NanoVibronix’s former stockholders owning the remaining 15 percent.
Haynes Boone Capital Markets Partners Rick Werner, Simin Sun and Alla Digilova led the core deal team with support from Associates Brent Duddles, Victoria Lee and Lisa Vasek.
Partner Sam Lichtman provided additional guidance along with Associates Daniel Imahiyerobo, Carleigh Lenz, Perry Laub, Kayla Cristales and Andrew Lo.
Haynes Boone's Capital Markets practice has played a leading role in numerous IPOs, reverse mergers, acquisitions, follow-on offerings and PIPE financings in recent years across sectors including technology, life sciences, energy and financial services. The firm provides comprehensive advice to clients trading on all major U.S. securities exchanges, over-the-counter markets and many foreign markets on a full range of securities transactions and reporting matters.
